David Thompson
Senior Vice President, Real World Research Syneos Health
David Thompson, PhD is a health economist who has been working in the field of HEOR since 1988. During the course of his career, he has developed expertise in economic modeling, retrospective database analysis, prospective real-world research, and patient-reported outcomes. His work has been global in nature, with extensive experience in North American & European markets as well as the emerging markets of the Asia-Pacific and Latin American regions. Dave is Senior Vice President, Real-World Research, at Syneos Health, a position he has held since 2016. Prior to joining Syneos Health, he held leadership positions at Quintiles (2012-2016), i3 Innovus/OptumInsight (2000-2012) and PAI (1988-2000).
WEDNESDAY, OCTOBER 28
10:30 AM Opportunities & Challenges for Using Real-World Data in Oncology Trials
Real-world data (RWD) is increasingly being used to facilitate and enhance clinical research in oncology. Opportunities for using RWD in oncology trials include assessing protocol feasibility by overlaying trial eligibility criteria onto a RWD source, identifying patients from RWD sources for inclusion in external control arms, and using RWD to augment data collection in long-term follow-up studies following gene therapy trials. However, it is easy to underestimate the challenges that arise in implementation.
This session will discuss the opportunities and challenges for RWD in oncology trials. Attendees will:
- Hear an overview of use of RWD sources in oncology trials
- What are the challenges related to use of RWD in any given trial
- Gain insight into opportunities to expand use of this approach with FDA, EMA and regulatory bodies around the world
The session will end with a live open question and answer discussion.
In Partnership With :
QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com
©2024 IQPC. All rights reserved.
